Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture

Metabolism: Clinical and Experimental

Volumn 49, Issue 5, 2000, Pages 666-671

  Gottschling Zeller, H ^a   Birgel, M ^a   Rohrig, K ^a   Hauner, H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; OBESITY; OMENTUM; PRIORITY JOURNAL; PROTEIN SECRETION; SUBCUTANEOUS FAT; TISSUE SPECIFICITY;

EID: 0034112096     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)80046-3     Document Type: Article

References (33)

1. Kissebah AH Krakower GR Regional adiposity and morbidity Physiol Rev 74 1994 761 811
2. Juhan-Vague I Alessi MC PAI-1, obesity, insulin resistance and risk of cardiovascular events Thromb Haemost 78 1997 656 660
3. Hekman CM Loskutoff DJ Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator Arch Biochem Biophys 2625 1988 199 210
4. Wiman B Chmielewska J Ranby M Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor J Biol Chem 259 1984 3644 3647
5. McGill J Schneider DJ Arfken CL Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients Diabetes 43 1994 104 109
6. De Pergola G De Mitrio V Scaraffia M Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men Metabolism 46 1997 1287 1293
7. De Pergola De Mitrio V Giorgino F Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: Relationship with body fat distribution Int J Obes Relat Metab Disord 21 1997 527 535
8. Janand-Delenne B Chaugnaud C Raccah D Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women Int J Obes Relat Metab Disord 22 1998 312 317
9. Vague P Juhan-Vague I Ailhaud MF Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects Metabolism 35 1986 250 253
10. Vague P Juhan-Vague I Chabert V Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women Metabolism 38 1989 913 915
11. Gray RP Panahollo A Mohamed-Ali V Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarction Atherosclerosis 130 1997 171 178
12. Juhan-Vague I Pyke SDM Alessi MC Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris Circulation 94 1996 2057 2063
13. Sawdey MS Loskutoff DJ Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β J Clin Invest 88 1991 1346 1353
14. Schneider DJ Sobel BE Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type 1: Implications for vascular disease in hyperinsulinemic states Proc Natl Acad Sci USA 88 1991 9959 9963
15. Schneider DJ Nordt TK Sobel BE Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients Diabetes 42 1993 1 7
16. van Hingsberg VW Kooistra T van den Berg EA Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo Blood 72 1988 1467 1473
17. Shimomura I Funahashi T Takanashi M Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity Nat Med 2 1996 800 803
18. Samad F Yamamoto K Loskutoff DJ Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-α and lipopolysaccharide J Clin Invest 97 1996 37 46
19. Samad F Yamamoto M Pandey M Elevated expression of transforming growth factor-β in adipose tissue from obese mice Mol Med 3 1997 37 48
20. Alessi MC Pirelli F Morange P Production of plasminogen activator inhibitor 1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease Diabetes 46 1997 860 867
21. Eriksson P Reynisdottir S Lönnqvist F Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals Diabetologia 41 1998 65 71
22. Hotamisligil GS Shargill NS Spiegelman BM Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance Science 259 1993 87 91
23. Cigolini M Tonoli M Borgato L Expression of plasminogen activator inhibitor-1 in human adipose tissue: A role for TNF-α? Atherosclerosis 143 1999 81 90
24. Fearns C Loskutoff DJ Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-α Am J Pathol 150 1997 579 590
25. Rodbell M Metabolism of isolated fat cell. I. Effects of hormones on glucose metabolism and lipolysis J Biol Chem 239 1964 375 380
26. Chomczynski P Sacchi N Single-step method for isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
27. Wabitsch M Jensen PB Blum WF Insulin and cortisol promote leptin production in cultured human fat cells Diabetes 45 1996 1435 1438
28. Loskutoff DJ Samad F The adipocytes and hemostatic balance in obesity. Studies of PAI-1 Arterioscler Thromb Vasc Biol 18 1998 1 6
29. Hekman CM Loskutoff DJ Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants J Biol Chem 260 1985 11581 11587
30. Nordt TK Schneider DJ Sobel BE Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for cardiovascular disease Circulation 89 1994 321 330
31. Velasquez EM Mendoza SG Wang P Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1. Lipoprotein(a) and immunoreactive insulin levels in patients with polycystic ovary syndrome Metabolism 46 1997 454 457
32. Glueck CJ Wang P Fontaine R Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with polycystic ovary syndrome Metabolism 48 1999 511 519
33. Lundgren CH Brown SL Nordt TK Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenic link between obesity and cardiovascular disease Circulation 93 1996 106 110